Zefia Uppal

DNP Doctor of Nursing Practice,  The Johns Hopkins Hospital 

Location: Germany

Consulting Services

Sales and Marketing Grant Submission Admin and Customer Support Journal Manuscript

Areas Of Interest

Oxyuroideas Glycogen Storage Cardiomyopathies Vestibular Nuclei Research Councils, National (U.S.) Brachypodium IL-15 Receptor Particle-Mediated Epidermal Delivery of DNA Plasticity, Brain TC45 Enzyme Doxycycline Calcium Conformations, Nucleic Acid System, Multi-Hospital Cerclage of Cervix DNA Amplification Technics CRD401 Volume, Mean Corpuscular Femoral Neoplasm Bronchial Diseases Rapid Fatigue of Gait Spinal Osteophytosis

Professional Narrative

Dr. Zefia Uppal was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Uppal has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 2010
Assistant Professor, Harvard Med 2005

Education

Doctor of osteopathic medicine, Yale School of Medicine 1989
Doctor of osteopathic medicine, Perelman School of Medicine 2009

Referees


Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :